Location: Suzhou, China
Date:
Event description: Novotech will be attending the CMAC Annual Meeting 2025, a key event focused on clinical value across the entire drug lifecycle. This year’s theme, "Embracing New Medical Knowledge and Harnessing Innovative Power," will drive discussions on global clinical development strategies and collaborative innovation in drug development. As a longstanding participant in the CMAC Annual Meeting, the focus this year will be on regulatory considerations, strategic approaches, and case studies in advanced therapies. The event provides a platform to highlight global clinical research capabilities and expertise in RNA-based therapies, reinforcing Novotech’s commitment to innovation in clinical development. Catherine Xu, Associate Director, Operational Strategy Lead, will present: "Clinical Strategy for RNA-based Therapies: Global Strategy" during the Challenges and Strategies in Globally Coordinated Clinical Development forum on March 19, 10:00–10:20 A.M. Meet with our team to discuss how Novotech’s expertise in global clinical development can support your program. Schedule a meeting via the form on this page.
This event has concluded
Thank you for your interest in Novotech at this event. While the event has ended, our experts continue to support sponsors across all stages of clinical development.